Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Flagship Ventures Fund V General Partner LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
08/15/2023 4 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Unknown transaction of 683,760 shares @ $14.92, valued at $10.2M
Unknown transaction of 113,960 shares @ $14.92, valued at $1.7M
08/14/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
06/08/2023 4 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Sana Biotechnology, Inc.
Txns: Sold 181,461 shares @ $6.3061, valued at $1.1M
Sold 22,297 shares @ $6.3061, valued at $140.6k
Sold 177,240 shares @ $6.2397, valued at $1.1M
Sold 22,760 shares @ $6.2397, valued at $142k
05/26/2023 4 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Sana Biotechnology, Inc.
Txns: Sold 308,290 shares @ $6.5652, valued at $2M
Sold 39,580 shares @ $6.5652, valued at $259.9k
Sold 102,245 shares @ $6.3522, valued at $649.5k
Sold 13,127 shares @ $6.3522, valued at $83.4k
Sold 72,670 shares @ $6.2265, valued at $452.5k
Sold 9,330 shares @ $6.2265, valued at $58.1k
02/14/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
11/14/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
09/16/2022 4 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Codiak BioSciences, Inc.
Txns: Bought 722,590 shares @ $0
Bought 210,743 shares @ $0
Bought 722,590 options to buy @ $1.875, valued at $1.4M
Bought 210,743 options to buy @ $1.875, valued at $395.1k
08/15/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/16/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/14/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
11/15/2021 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/16/2021 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/05/2021 4 Flagship Pioneering Inc. (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Converted 1,088,470 shares @ $0
Converted 5,896,386 shares @ $0
Converted 8,396,825 shares @ $0
Bought 220,588 shares @ $17, valued at $3.7M
Converted 970,588 shares @ $0
Converted 4,852,943 shares @ $0
Bought 661,764 shares @ $17, valued at $11.2M
Converted 1,323,529 shares @ $0
Bought 294,117 shares @ $17, valued at $5M
Converted 4,112,000 convertible preferred @ $0
Converted 22,275,232 convertible preferred @ $0
07/29/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
05/17/2021 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
03/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/16/2021 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
12/10/2020 4 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Converted 8,888,888 shares @ $0
Converted 1,481,481 shares @ $0
Converted 4,444,444 convertible preferred @ $0
Converted 4,074,074 convertible preferred @ $0
Converted 370,370 convertible preferred @ $0
Converted 1,481,481 convertible preferred @ $0
12/03/2020 3 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 3 on Sigilon Therapeutics, Inc.
11/16/2020 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
10/29/2020 4 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Foghorn Therapeutics Inc.
Txns: Converted 4,054,054 shares @ $0
Converted 4,504,504 shares @ $0
Converted 722,320 shares @ $0
Bought 50,000 shares @ $16, valued at $800k
Converted 1,441,441 shares @ $0
Bought 50,000 shares @ $16, valued at $800k
Converted 1,801,801 shares @ $0
Bought 50,000 shares @ $16, valued at $800k
Converted 7,500,000 convertible preferred @ $0
Converted 8,333,333 convertible preferred @ $0
Converted 1,336,293 convertible preferred @ $0
10/22/2020 3 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 3 on Foghorn Therapeutics Inc.
10/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
08/13/2020 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/14/2020 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/13/2020 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
11/14/2019 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/13/2019 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/14/2019 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
03/06/2019 4 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Converted 1,545,852 shares @ $0
Converted 4,637,555 shares @ $0
Converted 426,240 shares @ $0
Converted 639,360 shares @ $0
Converted 321,337 shares @ $0
Converted 964,010 shares @ $0
Converted 1,285,347 shares @ $0
Converted 625,625 shares @ $0
Converted 625,625 shares @ $0
Bought 266,667 shares @ $15, valued at $4M
Bought 333,333 shares @ $15, valued at $5M
02/27/2019 3 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 3 on Kaleido Biosciences, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy